In addition to its antilipidemic actions, FE acts as a peroxisome proliferator-activated receptor alpha (PPARα) agonist that has been reported to prevent the progression of DR and AMD in patients with diabetes. This evidence concerns the gene PPARA and diabetes mellitus.